BDBM356219 2-fluoro-5-(1-methyl-1H- pyrazol-3-yl)-N-(2-((2- oxopyrrolidin-1-yl)methyl)-4- phenylpyrimidin-5-yl)-4- (trifluoromethyl)benzamide::US9815846, Compound 219
SMILES: Cn1ccc(n1)-c1cc(C(=O)Nc2cnc(CN3CCCC3=O)nc2-c2ccccc2)c(F)cc1C(F)(F)F
InChI Key: InChIKey=AARXUGOQUWWYKI-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High affinity nerve growth factor receptor (Homo sapiens (Human)) | BDBM356219 (2-fluoro-5-(1-methyl-1H- pyrazol-3-yl)-N-(2-((2- o...) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.320 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description TrkA functional activity was measured using a DiscoverX PathHunter assay. In this assay, U2OS cells express the human TrkA receptor as a fusion with ... | US Patent US9815846 (2017) BindingDB Entry DOI: 10.7270/Q20P129R | |||||||||||
More data for this Ligand-Target Pair |